Morgan Stanley Knock-Out CVX/ DE000MB9Q2M1 /
31/05/2024 21:38:53 | Var.+0.27 | Denaro22:00:33 | Lettera22:00:33 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
4.28EUR | +6.73% | - Quantità in denaro: - |
- Quantità in lettera: - |
Chevron Corporation | 114.6312 USD | 31/12/2078 | Call |
GlobeNewswire
02:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
01:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering